Cargando…

Knowledge about breast cancer and hereditary breast cancer among nurses in a public hospital

OBJECTIVE: To assess the knowledge of nurses involved in the care of oncology patients in a public university hospital, regarding breast cancer and hereditary breast cancer, and to verify the use of such knowledge in their daily practice. METHODS: This is a descriptive cross-sectional study. Data we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prolla, Carmen Maria Dornelles, da Silva, Patrícia Santos, Netto, Cristina Brinckmann Oliveira, Goldim, José Roberto, Ashton-Prolla, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376036/ https://www.ncbi.nlm.nih.gov/pubmed/25806636 http://dx.doi.org/10.1590/0104-1169.0185.2529

Ejemplares similares

Prevalence and impact of founder mutations in hereditary breast cancer in Latin America
por: Ashton-Prolla, Patricia, et al.
Publicado: (2014)

Hereditary cancer syndromes: opportunities and challenges
por: Ashton-Prolla, Patricia
Publicado: (2013)

TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review
por: Rosset, Clévia, et al.
Publicado: (2017)

The Brazilian Hereditary Cancer Network: historical aspects and challenges for clinical cancer genetics in the public health care system in Brazil
por: Ashton-Prolla, Patricia, et al.
Publicado: (2016)

Tuberous Sclerosis Complex with rare associated findings in the gastrointestinal system: a case report and review of the literature
por: Reis, Larissa Brussa, et al.
Publicado: (2020)

Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil
por: Achatz, Maria Isabel, et al.
Publicado: (2020)

BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
por: Alemar, Bárbara, et al.
Publicado: (2017)

Correction: BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
por: Alemar, Bárbara, et al.
Publicado: (2018)

Cancer-related worry and risk perception in Brazilian individuals seeking genetic counseling for hereditary breast cancer
por: Palmero, Edenir Inêz, et al.
Publicado: (2020)

Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil
por: Palmero, Edenir I., et al.
Publicado: (2009)

Performance of the Gail and Tyrer-Cuzick breast cancer risk assessment models in women screened in a primary care setting with the FHS-7 questionnaire
por: Vianna, Fernanda Sales Luiz, et al.
Publicado: (2019)

The Development of the Study of Hereditary Cancer in South America
por: Rossi, Benedito Mauro, et al.
Publicado: (2016)

Haplotypic characterization of BRCA1 c.5266dupC, the prevailing mutation in Brazilian hereditary breast/ovarian cancer
por: Gomes, Renan, et al.
Publicado: (2020)

A DNA repair variant in POLQ (c.-1060A > G) is associated to hereditary breast cancer patients: a case–control study
por: Brandalize, Ana Paula Carneiro, et al.
Publicado: (2014)

Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
por: Ewald, Ingrid P, et al.
Publicado: (2011)

Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care
por: Ashton-Prolla, Patricia, et al.
Publicado: (2009)

Genetic variants involved in specialized DNA replication and their relation with breast cancer risk, disease progression and patient prognosis
por: Brandalize, Ana PC, et al.
Publicado: (2013)

Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis
por: Artigalás, Osvaldo, et al.
Publicado: (2015)

TP53 p.Arg337His germline mutation prevalence in Southern Brazil: Further evidence for mutation testing in young breast cancer patients
por: Hahn, Eriza Cristina, et al.
Publicado: (2018)

Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era
por: Macedo, Gabriel S., et al.
Publicado: (2019)

Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil
por: Giacomazzi, Juliana, et al.
Publicado: (2014)

Costs of genetic testing: Supporting Brazilian Public Policies for the incorporating of molecular diagnostic technologies
por: Schlatter, Rosane Paixão, et al.
Publicado: (2015)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
por: Ewald, Ingrid Petroni, et al.
Publicado: (2016)

Analysis of the interval between submission and publication in genetics journals
por: Zimmer, Rafael Leal, et al.
Publicado: (2023)

Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2016)

TULP3: A potential biomarker in colorectal cancer?
por: Sartor, Ivaine Taís Sauthier, et al.
Publicado: (2019)

miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review
por: Alemar, Bárbara, et al.
Publicado: (2015)

Fabry disease: Evidence for a regional founder effect of the GLA gene mutation 30delG in Brazilian patients
por: de Alencar, Dayse Oliveira, et al.
Publicado: (2014)

A model to optimize public health care and downstage breast cancer in limited-resource populations in southern Brazil. (Porto Alegre Breast Health Intervention Cohort)
por: Caleffi, Maira, et al.
Publicado: (2009)

Vitamin D Status and VDR Genotype in NF1 Patients: A Case-Control Study from Southern Brazil
por: Souza Mario Bueno, Larissa, et al.
Publicado: (2015)

Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional Study
por: Ossa Gomez, Carlos Andrés, et al.
Publicado: (2022)

Comparison of multiple genotyping methods for the identification of the cancer predisposing founder mutation p.R337H inTP53
por: Fitarelli-Kiehl, Mariana, et al.
Publicado: (2016)

Public Health Approaches and Barriers to Educating Providers about Hereditary Breast and Ovarian Cancer Syndrome
por: Trepanier, Angela M., et al.
Publicado: (2016)

Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population
por: da Costa e Silva Carvalho, Simone, et al.
Publicado: (2020)

Primary cells derived from Tuberous Sclerosis Complex patients show autophagy alteration in the haploinsufficiency state
por: Rosset, Clévia, et al.
Publicado: (2021)

Complete Response to Immunotherapy in a Patient with MUTYH-Associated Polyposis and Gastric Cancer: A Case Report
por: Mathias-Machado, Maria Cecilia, et al.
Publicado: (2023)

Synchronous Periampullary Tumors in a Patient With Pancreas Divisum and Neurofibromatosis Type 1
por: Gregório, Cleandra, et al.
Publicado: (2020)

TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient
por: Giacomazzi, Juliana, et al.
Publicado: (2013)

Genomic rearrangements in BRCA1 and BRCA2: A literature review
por: Ewald, Ingrid Petroni, et al.
Publicado: (2009)

Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1
por: Woycinck Kowalski, Thayne, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o6tiegjk7g92ggbudolr41ut5p